Eli Lilly and Company is a global biopharmaceutical leader headquartered in Indianapolis, Indiana. The company specializes in developing breakthrough treatments in cardiometabolic health, oncology, immunology, and neuroscience.
In recent years, it has achieved a dominant market position in diabetes and obesity care through its innovative dual-receptor agonists, Mounjaro and Zepbound. By combining aggressive research and development with massive manufacturing expansion and strategic acquisitions, Eli Lilly continues to drive medical innovation and improve life quality for patients worldwide.
Here are some articles to give you a basic understanding of the company:
Eli Lilly – background and history
Below is a list of articles for the company:
-
Eli Lilly – 2025 earnings
Q4 2025 Financial Performance Eli Lilly delivered robust growth driven by a surge in demand for its weight-loss and diabetes treatments. Key Product Performance Growth was spearheaded by the tirzepatide franchise, despite some pricing headwinds. R&D and Regulatory Progress Operational and Strategic Updates 2026 Financial Guidance The company issued an optimistic outlook for the coming…
-
Eli Lilly – 2025Q3 report
Here is the summary of Eli Lilly and Company’s Quarterly Report (Form 10-Q) for the period ended September 30, 2025, with reference numbers and separator lines removed: Financial Performance Overview Revenue for the third quarter of 2025 reached $17,600.8 million, a 54% increase compared to the third quarter of 2024. Net income for the third…
-
Eli Lilly – Competitions
Here is the competitive analysis for Eli Lilly in 2026, focused on its highest-revenue product categories. 2026 Strategic Outlook Table Category Key Product Top Rival 2026 Outlook Metabolism Mounjaro/Zepbound Novo Nordisk High growth; focus on oral pill (Orforglipron) launch. Oncology Verzenio Novartis Stable leadership in early-stage breast cancer. Immunology Taltz/Omvoh AbbVie Aggressive M&A to counter…
-
Eli Lilly – Background and History
The history of Eli Lilly and Company can be divided into several transformative eras: 1. Founding and Standardization (1876-1900s) Colonel Eli Lilly, a chemist and Civil War veteran, founded the company in 1876 in Indianapolis. At a time when many medicines were unreliable, he committed to scientific rigor. 2. The Insulin Revolution (1920s-1940s) Lilly transitioned…